Vol. 5 No. 2 (2023): Vol 5 No 2 (2023)

Articles

• A Critic on Legal, Ethical, and Regulatory Issues of Off-Label Medicines Shepardizing Intellectual Property Law towards Pharmacoeconomics: A Discussion of Pfizer's Norvasc Patent Case

  Zharama M. Llarena

  32 - 42

  • PDF

• Shepard's Validation of Antitrust Relief Framework on Patent Infringement of Novartis' Cancer Drug Using Genomic Architectures of Legal Literature Based on UK Intellectual Property Law

  Zharama M. Llarena

  1 - 9

  • PDF

• The Statutory Development for Criminal Responsibility based on International Trade Law of Aggressive Tax under Travaux Preparatoires: A Case Report of Joe Cinque

  Zharama Llarena

  43 - 53

  • PDF

• Legal Issues of Cardiovasc as Quality Drug Patented Product Based on Pharmaceutical Formulations Using Spectrophotometric Validation for Healthcare Corporate Governance

  Zharama M. Llarena

  10 - 31

  • PDF

• Plastic Waste Regime in Rwanda, Kenya and South Africa: A Comparative Case Study

  Onyinyechi Lilian Uche

  54 - 85

  • PDF